Mass spectrometry and imaging technologies in Geroscience

老年科学中的质谱和成像技术

基本信息

项目摘要

The 'Mass Spectrometry and Imaging Technologies in Geroscience1 P30 Core will consist of an integrated suite of mass spectrometry and microscopic imaging technologies coupled to specific protein and small molecule drug and metabolite analysis assays and bioenergetic analysis. The aims of this P30 Core are to integrate the unique instrumentation facilities at the Buck Institute in imaging and mass spectrometry to target the needs of the 10 components of the U54 in structural and functional proteomics, and for the analysis of drugs and targeted metabolites that constitute this Geroscience initiative. Specifically, the imaging and mass spectrometry technologies will encompass; (i) functional and fixed-cell imaging using protein-specific fluorophores and antibodies, (ii) functional analysis of intact neurons and other cells including bioenergetic and redox measurements, (iii) development and implementation of protein chemistries, (iv) mass spectrometry-based analysis of proteins, including their identification, quantitation, interactions and posttranslational modifications, (v) mass spectrometry imaging and profiling studies, and (vi) drug and metabolite analyses. These studies will be carried out on a range of aging and aging-related disease models that constitute the components of this U54. The P30 core will consist of two main but integrated parts: 'Functional and Structural Imaging Technologies' directed by Dr. Nicholls and 'Mass Spectrometry Technologies' directed by the principal investigator, Dr. Bradford Gibson. We propose to apply and integrate these instrument-based technologies at the very earliest stages of experimental design and work closely with the other investigators to develop, optimize, and implement these mass spectrometry and imaging technologies.
地质科学中的质谱和成像技术1 P30核心将包括一个综合的

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bradford Wayne Gibson其他文献

Bradford Wayne Gibson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bradford Wayne Gibson', 18)}}的其他基金

TripleTOF 5600 High Resolution Mass Spectrometer
TripleTOF 5600 高分辨率质谱仪
  • 批准号:
    8447837
  • 财政年份:
    2013
  • 资助金额:
    $ 91.93万
  • 项目类别:
BioAnalytical Chemistry Core B: Innate reponses to microbial infection
生物分析化学核心 B:对微生物感染的先天反应
  • 批准号:
    8305639
  • 财政年份:
    2011
  • 资助金额:
    $ 91.93万
  • 项目类别:
AB SCIEX QTRAP 5500 LC MS/MS system
AB SCIEX QTRAP 5500 LC MS/MS 系统
  • 批准号:
    7794815
  • 财政年份:
    2010
  • 资助金额:
    $ 91.93万
  • 项目类别:
BioAnalytical Chemistry Core B: Innate reponses to microbial infection
生物分析化学核心 B:对微生物感染的先天反应
  • 批准号:
    7920685
  • 财政年份:
    2010
  • 资助金额:
    $ 91.93万
  • 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
  • 批准号:
    8142537
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:
QSTAR Elite Quadrupole-o-TOF LC/MS/MS System
QSTAR Elite 四极杆-o-TOF LC/MS/MS 系统
  • 批准号:
    7389246
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
  • 批准号:
    7502168
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
  • 批准号:
    7898683
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
  • 批准号:
    7647091
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:
Mass spectrometry and imaging technologies in Geroscience
老年科学中的质谱和成像技术
  • 批准号:
    8130352
  • 财政年份:
    2007
  • 资助金额:
    $ 91.93万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 91.93万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 91.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了